More Good News for LGMD Patients
Sarepta shares jumped on Friday after the firm announced an update from its Duchenne muscular dystrophy trial.
All Work
Chris Lange
Is the FDA Going Too Soft on Zantac?
The FDA is coming down hard after the disclosure that Zantac and other generic ranitidine drugs could contain impurities and carcinogens.
Does Costco Deserve More Credit for Q4?
Costco shares slipped after it released mixed fiscal fourth-quarter financial results late on Thursday.
How Gen Z Could Drive a Record Holiday Season
With October clearly in the forefront, the Holiday Season is just around the corner and that means retail and e-commerce sales are about to start ramping up. In fact a recent forecast by Salesforce…
Are Americans Getting Enough Out of Airline and Hotel Rewards?
Nearly half of U.S. adults who participate in airline and hotel rewards programs have let their points or miles expire at some point, according to a new survey. Also among those who collect credit…
Plaque Psoriasis Suffers May Have Better Option After Eli Lilly Study
Eli Lilly announced some good news for people suffering moderate to severe plaque psoriasis when it presented at the 5th Annual Maui Derm NP+PA Fall meeting.
What to Expect When Costco Reports After the Close
Costco is scheduled to release its fiscal fourth-quarter financial results after the markets close on Thursday, and analysts are looking for solid growth year over year.
Is GoPro Done After This Delay?
GoPro shares were crushed on Thursday after the firm announced that there would be a delay in shipments of its new Hero8 Black cameras.
Why Canopy Growth Is Pulling Down Constellation Brands’ Earnings
Constellation Brands reported better than expected fiscal second-quarter earnings early Thursday but made a big change to its guidance.
Pepsi Pops Off in Q3
PepsiCo released better than expected third-quarter financial results before the markets opened on Thursday.
Bed Bath & Beyond Squeaks By in Q2
Bed Bath & Beyond reported its fiscal second quarter financial results after the markets closed on Wednesday. The retailer said that it had $0.34 in earnings per share (EPS) and $2.7 billion in revenue,…
What to Expect When Pepsi Reports Thursday Morning
PepsiCo is set to report its third-quarter financial results before the markets open on Thursday, and analysts are looking for growth on the bottom line.
Canopy Growth’s Next Step for Weed Domination
Canopy Growth shares dipped on Wednesday following the markets lower after the firm announced that it will purchase a majority stake in a leading producer of sports nutrition products.
What to Expect When Bed Bath & Beyond Reports After the Close
Bed Bath & Beyond is scheduled to release its fiscal second-quarter financial results after the markets close on Wednesday.
Will TSG and Flutter Get Lucky Creating the World’s Biggest Online Betting Site
The Stars Group shares exploded on Wednesday after the firm announced that it will be acquired by Flutter Entertainment in an all-share combination. This deal will form the world’s largest online betting company.
Johnson & Johnson May Have Just Dodged a Big Opioid Bullet
One analyst issued a fairly bullish report in response to Johnson & Johnson's announcement of a $10 million settlement with two Ohio counties ahead of an upcoming opioid trial.
FDA Accepts for Review the Newest Treatment for C Diff
Merck has just announced that the FDA has accepted a couple new drug applications for review, including for a treatment for Clostridium difficile infections in children.
Are Stitch Fix Earnings Big Enough to Fend Off the Bears?
Stitch Fix released its fiscal fourth quarter financial results after the markets closed on Tuesday. The after-hours session has seen ridiculous swings in the stock as the bulls and bears are fighting this one…
Would Stryker Be Better Off Buying Conformis?
Conformis shares shot up on Tuesday after the firm announced that it has entered into definitive agreements to sell and license to Stryker to develop, manufacture and supply PSI for use in connection with…
HBT Financial Gears Up for IPO
Bank holding company HBT Financial expects to price 8.3 million shares to result in an initial public offering valued up to more than $181 million.